Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3 RIMBP3C RIMBP3B	2.15e-06	5	121	3	GO:0030156
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	SETD1A SETD1B WDR5 KMT2A	5.77e-06	20	121	4	GO:0042800
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	SETD1A SETD1B KMT2A	1.19e-05	8	121	3	GO:0140945
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	SETD1A SETD1B KMT2A	2.52e-05	10	121	3	GO:0140999
GeneOntologyMolecularFunction	chromatin binding	FMR1 KAT6A NCAPH2 SKI STPG4 KAT7 SIRT2 SALL1 MTA3 ZC3H4 ASXL3 AUTS2 KMT2A MLLT3 BAHCC1	4.11e-05	739	121	15	GO:0003682
GeneOntologyMolecularFunction	histone modifying activity	SETD1A SETD1B KAT6A BAZ1B WDR5 KAT7 SIRT2 KMT2A	7.84e-05	229	121	8	GO:0140993
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	SETD1A SETD1B WDR5 KMT2A	1.44e-04	44	121	4	GO:0140938
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	SETD1A SETD1B WDR5 KMT2A	7.75e-04	68	121	4	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	SETD1A SETD1B WDR5 KMT2A	8.18e-04	69	121	4	GO:0016278
GeneOntologyMolecularFunction	histone methyltransferase activity	SETD1A SETD1B WDR5 KMT2A	9.11e-04	71	121	4	GO:0042054
GeneOntologyMolecularFunction	histone H4K16 acetyltransferase activity	KAT6A KAT7	1.28e-03	9	121	2	GO:0046972
GeneOntologyMolecularFunction	histone H3K14 acetyltransferase activity	KAT6A KAT7	1.28e-03	9	121	2	GO:0036408
GeneOntologyMolecularFunction	modification-dependent protein binding	FMR1 WDR5 KMT2A MLLT3 PML RAD23A	1.61e-03	206	121	6	GO:0140030
GeneOntologyMolecularFunction	translation initiation factor binding	FMR1 LARP1 NCK1	1.69e-03	39	121	3	GO:0031369
GeneOntologyMolecularFunction	histone H4K8 acetyltransferase activity	KAT6A KAT7	1.93e-03	11	121	2	GO:0043996
GeneOntologyMolecularFunction	histone H4K5 acetyltransferase activity	KAT6A KAT7	1.93e-03	11	121	2	GO:0043995
GeneOntologyCellularComponent	nuclear body	SETD1A SETD1B FMR1 TCF20 KAT6A ZC3H18 ZNF217 SKI SMC5 REXO1 PRCC CCNL1 SAFB2 ACIN1 SRRM2 THRAP3 PML	1.00e-05	903	116	17	GO:0016604
GeneOntologyCellularComponent	nuclear protein-containing complex	SETD1A MIS18BP1 SETD1B PAXX INTS1 BAZ1B WDR5 ZNF217 KAT7 SIRT2 BCL11B SALL1 MTA3 ASXL3 CCNL1 CPSF1 KMT2A ACIN1 MLLT3 SRRM2 THRAP3	2.06e-05	1377	116	21	GO:0140513
GeneOntologyCellularComponent	nuclear speck	SETD1A SETD1B KAT6A ZC3H18 ZNF217 SMC5 PRCC CCNL1 ACIN1 SRRM2 THRAP3	2.84e-05	431	116	11	GO:0016607
GeneOntologyCellularComponent	Set1C/COMPASS complex	SETD1A SETD1B WDR5	8.85e-05	16	116	3	GO:0048188
GeneOntologyCellularComponent	manchette	RIMBP3 RIMBP3C RIMBP3B	4.93e-04	28	116	3	GO:0002177
GeneOntologyCellularComponent	histone methyltransferase complex	SETD1A SETD1B WDR5 KMT2A	8.08e-04	75	116	4	GO:0035097
GeneOntologyCellularComponent	H3 histone acetyltransferase complex	KAT6A KAT7	8.36e-04	8	116	2	GO:0070775
HumanPheno	Bulbous nose	FMR1 TCF20 INTS1 SMC5 MESD ASXL3 KMT2A MYO18B SRRM2 SPEN WDR62	6.71e-07	201	44	11	HP:0000414
HumanPheno	Abnormal nasal tip morphology	FMR1 TCF20 KAT6A INTS1 SMC5 MESD ASXL3 AUTS2 KMT2A MYO18B SRRM2 SPEN WDR62	1.32e-05	386	44	13	HP:0000436
HumanPheno	Epicanthus	SETD1A TCF20 ADAMTS2 KAT6A INTS1 BAZ1B SKI SMC5 ZNF469 BCL11B CCDC88A ASXL3 AUTS2 KMT2A SRRM2 SPEN	2.63e-05	614	44	16	HP:0000286
HumanPheno	Deeply set eye	RALGAPA1 SETD1A FMR1 TCF20 KAT6A SKI ALKBH8 ASXL3 SRRM2 SPEN	6.51e-05	266	44	10	HP:0000490
Domain	Znf_FYVE_PHD	TCF20 PCLO KAT6A MYRIP BAZ1B PIKFYVE KMT2A ZFYVE26	3.54e-06	147	115	8	IPR011011
Domain	N-SET	SETD1A SETD1B	3.76e-05	2	115	2	PF11764
Domain	COMPASS_Set1_N-SET	SETD1A SETD1B	3.76e-05	2	115	2	IPR024657
Domain	N-SET	SETD1A SETD1B	3.76e-05	2	115	2	SM01291
Domain	Post-SET_dom	SETD1A SETD1B KMT2A	1.20e-04	16	115	3	IPR003616
Domain	PostSET	SETD1A SETD1B KMT2A	1.20e-04	16	115	3	SM00508
Domain	POST_SET	SETD1A SETD1B KMT2A	1.20e-04	16	115	3	PS50868
Domain	ZF_PHD_2	TCF20 KAT6A BAZ1B ASXL3 KMT2A	3.02e-04	95	115	5	PS50016
Domain	ZF_PHD_1	TCF20 KAT6A BAZ1B ASXL3 KMT2A	3.17e-04	96	115	5	PS01359
Domain	MOZ_SAS	KAT6A KAT7	3.71e-04	5	115	2	PF01853
Domain	HAT_MYST-type	KAT6A KAT7	3.71e-04	5	115	2	IPR002717
Domain	MYST_HAT	KAT6A KAT7	3.71e-04	5	115	2	PS51726
Domain	Znf_RING/FYVE/PHD	MYCBP2 PCLO KAT6A MYRIP BAZ1B PIKFYVE KMT2A IRF2BPL ZFYVE26 PML	5.44e-04	459	115	10	IPR013083
Domain	SH3_9	NCK1 RIMBP3 RIMBP3C RIMBP3B	1.37e-03	78	115	4	PF14604
Domain	Rap_GAP	RALGAPA1 RAP1GAP	1.64e-03	10	115	2	PF02145
Domain	-	MYCBP2 PCLO KAT6A MYRIP BAZ1B PIKFYVE KMT2A ZFYVE26 PML	1.84e-03	449	115	9	3.30.40.10
Domain	ZF_FYVE	MYRIP PIKFYVE ZFYVE26	1.90e-03	40	115	3	PS50178
Domain	BAH	MTA3 BAHCC1	1.99e-03	11	115	2	SM00439
Domain	Rap_GAP_dom	RALGAPA1 RAP1GAP	1.99e-03	11	115	2	IPR000331
Domain	RAPGAP	RALGAPA1 RAP1GAP	1.99e-03	11	115	2	PS50085
Domain	BAH	MTA3 BAHCC1	1.99e-03	11	115	2	PF01426
Domain	BAH	MTA3 BAHCC1	1.99e-03	11	115	2	PS51038
Domain	BAH_dom	MTA3 BAHCC1	1.99e-03	11	115	2	IPR001025
Domain	SET	SETD1A SETD1B KMT2A	2.04e-03	41	115	3	PF00856
Domain	SH3	ABL2 NCK1 RIMBP3 PRAM1 RIMBP3C RIMBP3B	2.21e-03	216	115	6	SM00326
Domain	SH3	ABL2 NCK1 RIMBP3 PRAM1 RIMBP3C RIMBP3B	2.21e-03	216	115	6	PS50002
Domain	PHD	TCF20 KAT6A BAZ1B KMT2A	2.23e-03	89	115	4	SM00249
Domain	Znf_PHD	TCF20 KAT6A BAZ1B KMT2A	2.41e-03	91	115	4	IPR001965
Domain	SH3_domain	ABL2 NCK1 RIMBP3 PRAM1 RIMBP3C RIMBP3B	2.42e-03	220	115	6	IPR001452
Domain	SET	SETD1A SETD1B KMT2A	2.85e-03	46	115	3	SM00317
Domain	SET_dom	SETD1A SETD1B KMT2A	3.61e-03	50	115	3	IPR001214
Domain	SET	SETD1A SETD1B KMT2A	3.61e-03	50	115	3	PS50280
Domain	-	SETD1A SETD1B ALKBH8 SAFB2 ACIN1 SPEN	4.03e-03	244	115	6	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	SETD1A SETD1B ALKBH8 SAFB2 ACIN1 SPEN	5.27e-03	258	115	6	IPR012677
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	SETD1A SETD1B KAT6A WDR5 KAT7 MTA3 KMT2A	3.93e-05	175	75	7	MM14941
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	SETD1A SETD1B WDR5 KMT2A	4.76e-05	38	75	4	MM17073
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	SETD1A SETD1B WDR5 KMT2A	7.10e-05	42	75	4	M48018
Pathway	REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION	SETD1A SETD1B WDR5 KMT2A	8.54e-05	44	75	4	MM15527
Pathway	REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES	SETD1A SETD1B WDR5 KMT2A	1.02e-04	46	75	4	MM14933
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	SETD1A SETD1B WDR5 AUTS2 KMT2A PML	1.61e-04	153	75	6	MM15522
Pathway	REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES	SETD1A SETD1B WDR5 KMT2A	5.20e-04	70	75	4	M27231
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	SETD1A SETD1B KAT6A WDR5 KAT7 MTA3 KMT2A	5.97e-04	272	75	7	M29619
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PDE4C TCF20 MYCBP2 GTSE1 LARP1 BAZ1B ZC3H18 ZNF217 REXO1 SCAF1 LIG1 SLC41A3 ZC3H4 CCNL1 ZBTB40 SAFB2 CPSF1 KMT2A ACIN1 IRF2BPL SRRM2 SPEN THRAP3 CXADR WDR62	2.33e-17	774	121	25	15302935
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	SETD1A SETD1B BAZ1B WDR5 ZC3H18 SCAF1 ZC3H4 SAFB2 CPSF1 KMT2A ACIN1 SPEN THRAP3	5.19e-12	251	121	13	31076518
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	SETD1A TCF20 INTS1 BAZ1B ZC3H18 PRCC ZC3H4 SAFB2 KMT2A ACIN1 SRRM2 SPEN THRAP3	2.34e-10	341	121	13	32971831
Pubmed	Interaction network of human early embryonic transcription factors.	SETD1A TCF20 BAZ1B WDR5 ZNF217 SKI BCL11B SALL1 ASXL3 AUTS2 KMT2A SPEN BAHCC1	3.33e-10	351	121	13	38297188
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 EHBP1 RAP1GAP ABL2 TCF20 MYCBP2 GTSE1 LARP1 FAM117B MAST2 PHLDB1 CCDC88A STARD9 KMT2A SRRM2 WDR62 ARAP2 PML	1.20e-09	861	121	18	36931259
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	TCF20 BAZ1B ZC3H18 BCL11B MTA3 KMT2A ACIN1 SPEN	3.06e-09	103	121	8	32744500
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	SETD1B KAT6A BAZ1B WDR5 KAT7 BCL11B MTA3 AUTS2 MLLT3	4.54e-09	157	121	9	30186101
Pubmed	The functional interactome landscape of the human histone deacetylase family.	MYCBP2 BAZ1B WDR5 ZNF217 BCL11B MTA3 CPSF1 ACIN1 SRRM2 THRAP3 PML	6.13e-09	289	121	11	23752268
Pubmed	The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.	SETD1A SETD1B WDR5 KMT2A	9.65e-09	8	121	4	22266653
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	CDCA3 FMR1 TCF20 GTSE1 NACA LIG1 PRCC ZC3H4 CCNL1 C1orf52 IRF2BPL SRRM2 PML	1.17e-08	472	121	13	38943005
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MIS18BP1 TCF20 INTS1 BAZ1B WDR5 ZC3H18 SMC5 KAT7 MTA3 ZNF532 SAFB2 CPSF1 KMT2A ACIN1 IRF2BPL THRAP3 PML RAD23A	1.51e-08	1014	121	18	32416067
Pubmed	Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.	SETD1A SETD1B WDR5 KMT2A	1.73e-08	9	121	4	22665483
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	FMR1 TCF20 KAT6A BAZ1B ZC3H18 KAT7 SCAF1 MTA3 SAFB2 ACIN1 THRAP3	2.40e-08	330	121	11	33301849
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MIS18BP1 TCF20 KAT6A INTS1 BAZ1B WDR5 ZC3H18 KAT7 MTA3 CCNL1 ZBTB40 KMT2A SPEN RAD23A	2.92e-08	608	121	14	36089195
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	SETD1A BAZ1B WDR5 KAT7 BCL11B MTA3 KMT2A ACIN1 SPEN	2.99e-08	195	121	9	19454010
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TCF20 GTSE1 LARP1 BAZ1B ZC3H18 SMC5 PRAM1 SALL1 PRCC ZC3H4 SAFB2 KMT2A ACIN1 SRRM2 SPEN THRAP3 PML	3.74e-08	954	121	17	36373674
Pubmed	Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.	SETD1A SETD1B WDR5 KMT2A	6.75e-08	12	121	4	27563068
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SETD1A FMR1 INTS1 ZC3H18 KAT7 LIG1 MTA3 ZC3H4 KMT2A ACIN1 SPEN PML	9.76e-08	469	121	12	27634302
Pubmed	Human transcription factor protein interaction networks.	SETD1A TCF20 NACA LARP1 BAZ1B WDR5 ZC3H18 ZNF217 SKI SALL1 MTA3 PRCC ZBTB40 AUTS2 CPSF1 KMT2A IRF2BPL SRRM2 SPEN PML	1.11e-07	1429	121	20	35140242
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MIS18BP1 SETD1B BAZ1B ZC3H18 ZNF217 RIMBP3 PIKFYVE SIRT2 CCDC88A SALL1 IQCC SPEN PML	1.50e-07	588	121	13	38580884
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3 RIMBP3C RIMBP3B	1.64e-07	4	121	3	19091768
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	SETD1A SETD1B WDR5 KAT7 ZC3H4 KMT2A RAD23A	2.10e-07	119	121	7	23508102
Pubmed	SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53.	SETD1A SETD1B WDR5 KMT2A	2.46e-07	16	121	4	23870121
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	FMR1 LARP1 BAZ1B WDR5 ZC3H18 KAT7 ZC3H4 SAFB2 CPSF1 KMT2A ACIN1 IRF2BPL SRRM2 THRAP3 WDR62	2.74e-07	847	121	15	35850772
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1A SETD1B MYCBP2 GTSE1 LAD1 KAT6A INTS1 MAST2 REXO1 PIKFYVE SCAF1 PHLDB1 SIRT2 CPSF1 ZFYVE26 SPEN BAHCC1	3.00e-07	1105	121	17	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	FMR1 KAT6A BAZ1B ZC3H18 SKI MAST2 KAT7 SCAF1 ZNF469 BCL11B MTA3 ZC3H4 SRRM2 WDR62 ARAP2 PML BAHCC1	3.45e-07	1116	121	17	31753913
Pubmed	Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.	KAT6A WDR5 KMT2A	4.09e-07	5	121	3	20581860
Pubmed	Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation.	SETD1A SETD1B KMT2A	4.09e-07	5	121	3	25561738
Pubmed	A gene-targeting approach for functional characterization of KIAA genes encoding extremely large proteins.	INTS1 KNDC1 BAHCC1	4.09e-07	5	121	3	16807365
Pubmed	Structure and evolution of RIM-BP genes: identification of a novel family member.	RIMBP3 RIMBP3C RIMBP3B	4.09e-07	5	121	3	17855024
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	FMR1 NACA BAZ1B WDR5 ZC3H18 PFKFB3 KAT7 SAFB2 CPSF1 ACIN1 SRRM2 THRAP3 PML	5.54e-07	660	121	13	32780723
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	TCF20 MYCBP2 GTSE1 NACA INTS1 BAZ1B SCAF1 PHLDB1 ZC3H4 SAFB2 CPSF1 ACIN1 SRRM2 SPEN THRAP3 CXADR	5.64e-07	1024	121	16	24711643
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MYCBP2 ZC3H18 MAST2 SCAF1 PHLDB1 ASXL3 MYO18B SRRM2 SPEN THRAP3	5.85e-07	361	121	10	26167880
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	SETD1A SETD1B WDR5 ASXL3	6.47e-07	20	121	4	29785026
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	TCF20 PAXX BAZ1B ZC3H18 ZC3H4 SAFB2 ACIN1 SPEN THRAP3	7.02e-07	283	121	9	30585729
Pubmed	GRWD1-WDR5-MLL2 Epigenetic Complex Mediates H3K4me3 Mark and Is Essential for Kaposi's Sarcoma-Associated Herpesvirus-Induced Cellular Transformation.	SETD1A WDR5 KMT2A	8.15e-07	6	121	3	34933446
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EHBP1 NACA LARP1 BAZ1B SIRT2 FAM193A PRCC ZC3H4 SAFB2 C1orf52 KMT2A ACIN1 SMCR8 WDR62 PML	9.33e-07	934	121	15	33916271
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 EHBP1 MYCBP2 KAT6A MYRIP LARP1 FAM117B SKI SHROOM2 ARMC2 HPS3 BICD1 PHLDB1 MTA3 SLC41A3 ZNF532 KNDC1 AUTS2 THRAP3	9.65e-07	1489	121	19	28611215
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	SETD1A SETD1B WDR5 KMT2A	9.71e-07	22	121	4	26886794
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	MIS18BP1 TCF20 GTSE1 WDR5 NCAPH2 REXO1 SALL1 PML	1.18e-06	222	121	8	37071664
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	TCF20 PCLO LARP1 ZNF217 PFKFB3 BCL11B SALL1 AUTS2 SMCR8 BAHCC1	1.41e-06	398	121	10	35016035
Pubmed	CXXC finger protein 1 contains redundant functional domains that support embryonic stem cell cytosine methylation, histone methylation, and differentiation.	SETD1A SETD1B WDR5	1.42e-06	7	121	3	19433449
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	FMR1 LARP1 BAZ1B ZC3H18 KAT7 BCL11B MTA3 KMT2A ACIN1 SRRM2 SPEN THRAP3	1.44e-06	605	121	12	28977666
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TCF20 MYCBP2 LARP1 ZNF217 LIG1 PRAM1 MTA3 ZBTB40 SAFB2 C1orf52 KMT2A SRRM2 SPEN THRAP3 PML RAD23A	1.49e-06	1103	121	16	34189442
Pubmed	New nomenclature for chromatin-modifying enzymes.	SETD1A SETD1B KAT6A KAT7 KMT2A	1.70e-06	57	121	5	18022353
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1B TCF20 SMC5 PHLDB1 STARD9 ACIN1 SRRM2 SPEN PLXNA2 ARAP2	1.72e-06	407	121	10	12693553
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	RALGAPA1 TCF20 MYCBP2 NACA LARP1 NCK1 PIKFYVE MESD CCDC88A FAM193A C1orf52 ROBO1 WDR62	1.77e-06	733	121	13	34672954
Pubmed	CFP1 interacts with DNMT1 independently of association with the Setd1 Histone H3K4 methyltransferase complexes.	SETD1A SETD1B WDR5	2.27e-06	8	121	3	18680430
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	SETD1A SETD1B KMT2A	2.27e-06	8	121	3	23130995
Pubmed	Role of PML and PML-RARalpha in Mad-mediated transcriptional repression.	SKI PRAM1 PML	2.27e-06	8	121	3	11430826
Pubmed	Identification and characterization of the human Set1B histone H3-Lys4 methyltransferase complex.	SETD1A SETD1B WDR5	2.27e-06	8	121	3	17355966
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGAPA1 SETD1A NACA LARP1 MESD CCDC88A MTA3 ZNF532 ZC3H4 EFR3B AUTS2	2.57e-06	529	121	11	14621295
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	FMR1 TCF20 INTS1 BAZ1B WDR5 ZC3H18 NCAPH2 SKI KAT7 SCAF1 SAFB2 CPSF1 KMT2A ACIN1 SRRM2 SPEN THRAP3	2.59e-06	1294	121	17	30804502
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	FMR1 TCF20 MYCBP2 INTS1 LARP1 BAZ1B ZC3H18 CPSF1 KMT2A ACIN1 SRRM2 SPEN	3.16e-06	653	121	12	22586326
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RALGAPA1 CDCA3 MYCBP2 BAZ1B CCDC88A FAM193A PRCC EFR3B C1orf52 ROBO1 SRRM2 SMCR8 ZNHIT2 QRSL1 CXADR WDR62 PML RAD23A	4.01e-06	1487	121	18	33957083
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	LARP1 NCK1 ZC3H4 CCNL1 KMT2A SRRM2 SRRM3	4.22e-06	186	121	7	33637726
Pubmed	Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.	LARP1 ZC3H18 CCNL1 SAFB2 ACIN1 SRRM2 THRAP3	4.53e-06	188	121	7	29721183
Pubmed	Wdr82 is a C-terminal domain-binding protein that recruits the Setd1A Histone H3-Lys4 methyltransferase complex to transcription start sites of transcribed human genes.	SETD1A SETD1B WDR5	4.84e-06	10	121	3	17998332
Pubmed	Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1/COMPASS.	SETD1A SETD1B WDR5	4.84e-06	10	121	3	18838538
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	MYCBP2 GTSE1 LARP1 ZC3H18 ZC3H4 STARD9 ACIN1 SRRM2 THRAP3	5.15e-06	361	121	9	30344098
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	RALGAPA1 FMR1 MYCBP2 PCLO INTS1 LARP1 WDR5 MAST2 FAM193A THRAP3	5.28e-06	462	121	10	31138677
Pubmed	Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression.	SETD1A WDR5 KMT2A	6.64e-06	11	121	3	18082152
Pubmed	MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program.	WDR5 NFAM1 KMT2A	8.83e-06	12	121	3	27462455
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EHBP1 RAP1GAP CC2D1B ANKRD6 REXO1 PIKFYVE TTBK1 PER3 SAFB2 IRF2BPL	9.30e-06	493	121	10	15368895
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	RALGAPA1 TCF20 BAZ1B WDR5 ZNF217 KAT7 SCAF1 LIG1 ZC3H4 SAFB2 ACIN1 SRRM2 THRAP3 PML	9.31e-06	989	121	14	36424410
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	NACA LARP1 WDR5 ZC3H18 PHLDB1 ZC3H4 SAFB2 CPSF1 ACIN1 SRRM2 SPEN THRAP3	9.85e-06	731	121	12	29298432
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CYP2A13 ABI3BP PCLO MYRIP LARP1 CC2D1B SKI STS STARD9 SAFB2 KMT2A ACIN1 SPEN THRAP3 PLXNA2 CFAP46 BAHCC1	1.08e-05	1442	121	17	35575683
Pubmed	MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.	KMT2A MLLT3	1.20e-05	2	121	2	27344946
Pubmed	Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5.	WDR5 KMT2A	1.20e-05	2	121	2	22989411
Pubmed	Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related cases.	KMT2A MLLT3	1.20e-05	2	121	2	20395514
Pubmed	Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.	KMT2A MLLT3	1.20e-05	2	121	2	32768438
Pubmed	The planar cell polarity (PCP) protein Diversin translocates to the nucleus to interact with the transcription factor AF9.	ANKRD6 MLLT3	1.20e-05	2	121	2	19591803
Pubmed	Impact of MLL::AF9 Gene Rearrangement on Survival of Acute Myeloid Leukaemia Patients: An Insight into Pakistani Population.	KMT2A MLLT3	1.20e-05	2	121	2	38576284
Pubmed	MLL-AF9 regulates transcriptional initiation in mixed lineage leukemic cells.	KMT2A MLLT3	1.20e-05	2	121	2	39002676
Pubmed	Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia.	KMT2A MLLT3	1.20e-05	2	121	2	21959947
Pubmed	MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny.	KMT2A MLLT3	1.20e-05	2	121	2	23178754
Pubmed	The H3K4 methyltransferase Setd1a is first required at the epiblast stage, whereas Setd1b becomes essential after gastrulation.	SETD1A SETD1B	1.20e-05	2	121	2	24550110
Pubmed	HBO1 is required for the maintenance of leukaemia stem cells.	KAT6A KAT7	1.20e-05	2	121	2	31827282
Pubmed	High-affinity small molecular blockers of mixed lineage leukemia 1 (MLL1)-WDR5 interaction inhibit MLL1 complex H3K4 methyltransferase activity.	WDR5 KMT2A	1.20e-05	2	121	2	27598236
Pubmed	HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.	KAT7 KMT2A	1.20e-05	2	121	2	34431785
Pubmed	Inhibiting MLL1-WDR5 interaction ameliorates neuropathic allodynia by attenuating histone H3 lysine 4 trimethylation-dependent spinal mGluR5 transcription.	WDR5 KMT2A	1.20e-05	2	121	2	32345914
Pubmed	Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development.	KMT2A MLLT3	1.20e-05	2	121	2	11265751
Pubmed	In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F).	SETD1A SETD1B	1.20e-05	2	121	2	38003223
Pubmed	WDR5 high expression and its effect on tumorigenesis in leukemia.	WDR5 KMT2A	1.20e-05	2	121	2	27192115
Pubmed	An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model.	KMT2A MLLT3	1.20e-05	2	121	2	22427200
Pubmed	KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements.	KAT7 KMT2A	1.20e-05	2	121	2	32764680
Pubmed	Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks.	KMT2A MLLT3	1.20e-05	2	121	2	30387535
Pubmed	Oncogenic ZMYND11-MBTD1 fusion protein anchors the NuA4/TIP60 histone acetyltransferase complex to the coding region of active genes.	ZC3H18 KMT2A ACIN1 SRRM2	1.41e-05	42	121	4	35705031
Pubmed	Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library.	RIMBP3 RIMBP3C RIMBP3B	1.45e-05	14	121	3	17662146
Pubmed	The lysine acetyltransferase activator Brpf1 governs dentate gyrus development through neural stem cells and progenitors.	KAT6A KAT7 BCL11B	1.45e-05	14	121	3	25757017
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYCBP2 SMC5 MESD PHLDB1 ZC3H4 ZBTB40 AUTS2	1.46e-05	225	121	7	12168954
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	EHBP1 TCF20 MYCBP2 ZNF217 CCDC88A FAM193A SALL1 ZNF532 WDR62	1.66e-05	418	121	9	34709266
Pubmed	An expanded Oct4 interaction network: implications for stem cell biology, development, and disease.	ZNF217 KAT7 SALL1 MTA3 ACIN1	1.72e-05	91	121	5	20362542
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ABL2 GTSE1 KAT6A LARP1 BAZ1B ZNF217 ZC3H4 IRF2BPL	2.24e-05	332	121	8	37433992
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SETD1A TCF20 MYCBP2 LARP1 BAZ1B NCK1 KMT2A ACIN1 SPEN THRAP3	2.34e-05	549	121	10	38280479
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	FMR1 NACA LARP1 PFKFB3 SKI CCDC88A ZC3H4 CPSF1 THRAP3 PML	2.41e-05	551	121	10	34728620
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	MIS18BP1 GTSE1 WDR5 ZNF217 KAT7 KMT2A SPEN PML	2.60e-05	339	121	8	30415952
Pubmed	A method to identify cDNAs based on localization of green fluorescent protein fusion products.	KAT6A ACIN1 PML	2.70e-05	17	121	3	10716735
Pubmed	Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.	SETD1A SETD1B WDR5 KMT2A	2.84e-05	50	121	4	37974198
Pubmed	The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair.	RALGAPA1 FAM117B LIG1 MLLT3 WDR62	3.59e-05	106	121	5	31024071
Interaction	ZBTB2 interactions	FMR1 TCF20 KAT6A BAZ1B WDR5 ZC3H18 KAT7 SCAF1 LIG1 MESD MTA3 SAFB2 ACIN1 QRSL1 THRAP3	7.53e-08	450	120	15	int:ZBTB2
Interaction	HMGA1 interactions	TCF20 PCLO KAT6A BAZ1B WDR5 ZC3H18 SMC5 KAT7 SAFB2 KMT2A ROBO1 SPEN THRAP3 CFAP46	2.05e-07	419	120	14	int:HMGA1
Interaction	SSRP1 interactions	KAT6A INTS1 WDR5 ZC3H18 SMC5 REXO1 KAT7 SCAF1 MTA3 ZC3H4 SAFB2 CPSF1 KMT2A ACIN1 EMX2 SRRM2 THRAP3	6.43e-07	685	120	17	int:SSRP1
Interaction	CHD4 interactions	SETD1A FMR1 TCF20 KAT6A LARP1 BAZ1B WDR5 ZC3H18 SMC5 KAT7 BCL11B SALL1 MTA3 KMT2A ACIN1 MLLT3 SRRM2 SPEN THRAP3 PML	6.62e-07	938	120	20	int:CHD4
Interaction	MEN1 interactions	SETD1A SETD1B TCF20 INTS1 LARP1 BAZ1B WDR5 ZC3H18 KAT7 PRCC ZC3H4 SAFB2 CPSF1 KMT2A ACIN1 IRF2BPL SRRM2 SPEN THRAP3 WDR62 RAD23A	6.82e-07	1029	120	21	int:MEN1
Interaction	SFN interactions	RALGAPA1 SETD1A RAP1GAP ABL2 MYCBP2 LAD1 LARP1 FAM117B ZC3H18 MAST2 KAT7 PHLDB1 CCDC88A KMT2A SRRM2 WDR62 ARAP2	7.40e-07	692	120	17	int:SFN
Interaction	CSNK2A1 interactions	SETD1A FMR1 KAT6A NACA LARP1 WDR5 ZC3H18 ZNF217 KAT7 LIG1 PRCC ZC3H4 ASXL3 CCNL1 AUTS2 KMT2A ACIN1 SRRM2 THRAP3 PML	8.90e-07	956	120	20	int:CSNK2A1
Interaction	DYRK2 interactions	SETD1B GTSE1 LARP1 WDR5 ZC3H18 CCDC88A CPSF1 SRRM2 WDR62	9.50e-07	173	120	9	int:DYRK2
Interaction	SNRNP40 interactions	MIS18BP1 TCF20 KAT6A WDR5 ZC3H18 ZNF217 SCAF1 ZNF532 PRCC ZC3H4 KMT2A ACIN1 SRRM2 SPEN ZNHIT2 PML	1.21e-06	637	120	16	int:SNRNP40
Interaction	MBD3 interactions	FMR1 BAZ1B WDR5 ZC3H18 SMC5 BCL11B SALL1 MTA3 KMT2A SRRM2 SPEN	1.55e-06	295	120	11	int:MBD3
Interaction	KAT8 interactions	SETD1A SETD1B KAT6A BAZ1B WDR5 KAT7 KMT2A	1.59e-06	95	120	7	int:KAT8
Interaction	RBBP4 interactions	SETD1A TCF20 WDR5 ZC3H18 SMC5 BCL11B SALL1 MTA3 ZNF532 ASXL3 KMT2A SRRM2 SPEN THRAP3 BAHCC1	1.62e-06	573	120	15	int:RBBP4
Interaction	H3-3A interactions	SETD1A SETD1B TCF20 KAT6A INTS1 BAZ1B WDR5 SMC5 KAT7 MTA3 CCNL1 ZBTB40 KMT2A MLLT3 SPEN THRAP3 PML	2.18e-06	749	120	17	int:H3-3A
Interaction	TOP1 interactions	TCF20 KAT6A LARP1 BAZ1B ZC3H18 SMC5 SCAF1 LIG1 ZC3H4 ASXL3 SAFB2 CPSF1 KMT2A ACIN1 SRRM2 THRAP3	3.79e-06	696	120	16	int:TOP1
Interaction	NUP50 interactions	SETD1A TCF20 NACA SMC5 PRCC ZC3H4 C1orf52 KMT2A SRRM2 SPEN PML	6.22e-06	341	120	11	int:NUP50
Interaction	H3C1 interactions	SETD1A SETD1B KAT6A NACA INTS1 LARP1 BAZ1B WDR5 SMC5 PIKFYVE KAT7 SIRT2 MTA3 ZC3H4 KMT2A MLLT3 SPEN THRAP3	6.33e-06	901	120	18	int:H3C1
Interaction	EWSR1 interactions	FMR1 TCF20 MYCBP2 PCLO KAT6A NACA WDR5 ZC3H18 ZNF217 SMC5 SIRT2 PRCC SAFB2 C1orf52 KMT2A THRAP3 CXADR RAD23A	6.83e-06	906	120	18	int:EWSR1
Interaction	CBX3 interactions	SETD1A MIS18BP1 FMR1 TCF20 BAZ1B WDR5 ZNF217 SMC5 LIG1 PRCC ZC3H4 C1orf52 KMT2A SRRM2 SPEN	6.94e-06	646	120	15	int:CBX3
Interaction	YEATS2 interactions	SETD1A SETD1B WDR5 NCAPH2 SMC5 CPSF1 KMT2A PML	7.84e-06	169	120	8	int:YEATS2
Interaction	YWHAZ interactions	RALGAPA1 RAP1GAP ABL2 MYCBP2 KAT6A LARP1 FAM117B WDR5 ZC3H18 PFKFB3 SMC5 MAST2 PHLDB1 CCDC88A PRCC STARD9 ASXL3 C1orf52 KMT2A WDR62 ARAP2 PML	9.67e-06	1319	120	22	int:YWHAZ
Interaction	RBBP7 interactions	TCF20 MYCBP2 WDR5 ZC3H18 SMC5 BCL11B CCDC88A SALL1 MTA3 KMT2A SPEN THRAP3 BAHCC1	1.05e-05	507	120	13	int:RBBP7
Interaction	YWHAG interactions	RALGAPA1 EHBP1 RAP1GAP ABL2 MYCBP2 GTSE1 LARP1 FAM117B PFKFB3 MAST2 SHROOM2 PHLDB1 TTBK1 CCDC88A STARD9 KMT2A ACIN1 SRRM2 THRAP3 WDR62 ARAP2	1.39e-05	1248	120	21	int:YWHAG
Interaction	PHF20 interactions	SETD1A SETD1B WDR5 LIG1 KMT2A	1.57e-05	53	120	5	int:PHF20
Interaction	H2BC21 interactions	TCF20 PCLO KAT6A BAZ1B CC2D1B WDR5 ZC3H18 KAT7 MESD ZC3H4 SAFB2 KMT2A SRRM2 CFAP46 BAHCC1	1.67e-05	696	120	15	int:H2BC21
Interaction	RAD18 interactions	SETD1A BAZ1B ZC3H18 SMC5 SCAF1 ZC3H4 SAFB2 CPSF1 ACIN1 SRRM2 SPEN THRAP3	1.85e-05	457	120	12	int:RAD18
Interaction	RERE interactions	SETD1A SETD1B KAT6A WDR5 AUTS2 KMT2A	1.96e-05	93	120	6	int:RERE
Interaction	ZNF608 interactions	SETD1A SETD1B WDR5 AUTS2 KMT2A PML	1.96e-05	93	120	6	int:ZNF608
Interaction	ZZZ3 interactions	SETD1A SETD1B WDR5 NCAPH2 SMC5 KMT2A PML	1.98e-05	139	120	7	int:ZZZ3
Interaction	PPIA interactions	CDCA3 FMR1 TCF20 GTSE1 NACA ZC3H18 SMC5 LIG1 PHLDB1 PRCC ZC3H4 STARD9 CCNL1 C1orf52 IRF2BPL SRRM2 PML	2.03e-05	888	120	17	int:PPIA
Interaction	NUP43 interactions	SETD1A MIS18BP1 SETD1B TCF20 LARP1 WDR5 ZC3H18 SCAF1 CCDC88A ZNF532 KMT2A ACIN1 SRRM2 SPEN	2.14e-05	625	120	14	int:NUP43
Interaction	KANSL1 interactions	SETD1A SETD1B KAT6A BAZ1B WDR5 KMT2A	2.35e-05	96	120	6	int:KANSL1
Interaction	TERF2IP interactions	SETD1A TCF20 INTS1 WDR5 ZC3H18 MTA3 PRCC ZC3H4 C1orf52 KMT2A SRRM2 SPEN PML	2.56e-05	552	120	13	int:TERF2IP
Interaction	SUPT5H interactions	TCF20 INTS1 BAZ1B ZC3H18 SCAF1 ZC3H4 SAFB2 KMT2A ACIN1 SPEN THRAP3	3.29e-05	408	120	11	int:SUPT5H
Interaction	SKAP1 interactions	MYCBP2 CC2D1B NCAPH2 HPS3 PRAM1 ZNHIT2	3.32e-05	102	120	6	int:SKAP1
Interaction	XRCC6 interactions	TCF20 PAXX INTS1 BAZ1B WDR5 ZC3H18 SMC5 ZC3H4 ASXL3 SAFB2 KMT2A ACIN1 EMX2 SRRM2 SPEN QRSL1 THRAP3	3.55e-05	928	120	17	int:XRCC6
Interaction	THOC1 interactions	FMR1 GTSE1 ZC3H18 SMC5 SCAF1 LIG1 SPEN THRAP3	3.77e-05	210	120	8	int:THOC1
Interaction	DENND2D interactions	C1orf52 ACIN1 MLLT3 SRRM2	6.08e-05	36	120	4	int:DENND2D
Interaction	NCOR1 interactions	FMR1 NCAPH2 SKI SMC5 PRAM1 SAFB2 CPSF1 SPEN CXADR PML	6.37e-05	363	120	10	int:NCOR1
Interaction	SAP30 interactions	SETD1B WDR5 ZNF217 BCL11B MTA3 KMT2A BAHCC1	6.42e-05	167	120	7	int:SAP30
Interaction	SNRPC interactions	LARP1 WDR5 ZC3H18 NCAPH2 SMC5 SAFB2 CPSF1 ACIN1 SRRM2 SPEN THRAP3	6.51e-05	440	120	11	int:SNRPC
Interaction	DCAF7 interactions	GTSE1 FAM117B ZNF217 PFKFB3 SKI LIG1 ZNF532 KNDC1 AUTS2 SRRM2	7.14e-05	368	120	10	int:DCAF7
Interaction	CAMKV interactions	ZC3H18 ACIN1 MLLT3 SRRM2 SPEN THRAP3	7.52e-05	118	120	6	int:CAMKV
Interaction	SULF2 interactions	SETD1A ZC3H18 ACIN1 MLLT3 SRRM2 SPEN	7.89e-05	119	120	6	int:SULF2
Interaction	PHF20L1 interactions	SETD1A SETD1B WDR5 MTA3 KMT2A	8.52e-05	75	120	5	int:PHF20L1
Interaction	TLE3 interactions	TCF20 WDR5 ZNF217 BCL11B FAM193A SALL1 AUTS2 KMT2A SRRM2 SPEN	8.53e-05	376	120	10	int:TLE3
Interaction	SMC5 interactions	TCF20 GTSE1 LARP1 BAZ1B ZC3H18 SMC5 PRAM1 SALL1 PRCC ZC3H4 SAFB2 KMT2A ACIN1 SRRM2 SPEN THRAP3 PML	8.94e-05	1000	120	17	int:SMC5
Interaction	YWHAH interactions	RALGAPA1 EHBP1 RAP1GAP ABL2 TCF20 MYCBP2 GTSE1 LARP1 FAM117B PFKFB3 MAST2 PHLDB1 CCDC88A STARD9 KMT2A SRRM2 WDR62 ARAP2	9.05e-05	1102	120	18	int:YWHAH
Interaction	MEX3A interactions	RAP1GAP ABL2 FMR1 GTSE1 KAT6A LARP1 BAZ1B ZNF217 ZC3H4 IRF2BPL	1.01e-04	384	120	10	int:MEX3A
Interaction	GATAD2B interactions	TCF20 NCAPH2 SMC5 BCL11B SALL1 MTA3 IRF2BPL PML	1.11e-04	245	120	8	int:GATAD2B
Interaction	KMT2A interactions	SETD1A SETD1B KAT6A WDR5 SMC5 NFAM1 KMT2A MLLT3 PML	1.11e-04	314	120	9	int:KMT2A
Interaction	ATN1 interactions	SETD1A SETD1B KAT6A WDR5 KAT7 AUTS2 KMT2A	1.30e-04	187	120	7	int:ATN1
Interaction	DDX5 interactions	RALGAPA1 SETD1A FMR1 KAT6A NACA WDR5 ZC3H18 ZNF217 SKI SMC5 SRRM2 THRAP3	1.48e-04	568	120	12	int:DDX5
Interaction	ZMYND8 interactions	FMR1 INTS1 SMC5 BCL11B MTA3 ZNF532 ARAP2	1.48e-04	191	120	7	int:ZMYND8
Interaction	KANSL3 interactions	SETD1A SETD1B WDR5 KMT2A PML	1.63e-04	86	120	5	int:KANSL3
Interaction	H2BC5 interactions	PCLO BAZ1B CC2D1B NCK1 ZC3H18 SMC5 SCAF1 KMT2A SRRM2	1.65e-04	331	120	9	int:H2BC5
Interaction	CHD3 interactions	FMR1 KAT6A LARP1 BAZ1B WDR5 ZC3H18 SMC5 BCL11B SALL1 MTA3 CPSF1 KMT2A ACIN1 THRAP3	1.66e-04	757	120	14	int:CHD3
Interaction	GSC interactions	SKI SALL1 ASXL3 AUTS2 BAHCC1	1.72e-04	87	120	5	int:GSC
Interaction	H3C3 interactions	MIS18BP1 TCF20 BAZ1B WDR5 ZC3H18 KAT7 MTA3 CCNL1 KMT2A SPEN RAD23A	1.83e-04	495	120	11	int:H3C3
Interaction	PRPF6 interactions	KAT6A WDR5 ZC3H18 SMC5 ACIN1 SRRM2 ZNHIT2 THRAP3 PML	1.85e-04	336	120	9	int:PRPF6
Interaction	NUPR1 interactions	FMR1 NACA BAZ1B WDR5 ZC3H18 PFKFB3 KAT7 SAFB2 CPSF1 ACIN1 SRRM2 THRAP3 PML	2.18e-04	683	120	13	int:NUPR1
Interaction	DPY30 interactions	SETD1A SETD1B KAT6A WDR5 KAT7 MTA3 KMT2A	2.23e-04	204	120	7	int:DPY30
Interaction	NAA40 interactions	EHBP1 NACA LARP1 BAZ1B SMC5 SIRT2 FAM193A PRCC ZC3H4 SAFB2 C1orf52 KMT2A ACIN1 SMCR8 WDR62 PML	2.27e-04	978	120	16	int:NAA40
Interaction	SRSF7 interactions	LARP1 WDR5 ZC3H18 SMC5 SCAF1 SIRT2 ACIN1 SRRM2 SPEN THRAP3	2.31e-04	425	120	10	int:SRSF7
Interaction	NFKBIL1 interactions	SETD1A ZC3H18 ACIN1 SRRM2 SPEN	2.36e-04	93	120	5	int:NFKBIL1
Interaction	H3C15 interactions	NCK1 ZC3H18 SMC5 KMT2A SRRM2 THRAP3 PML	2.43e-04	207	120	7	int:H3C15
Interaction	DEK interactions	KAT6A BAZ1B WDR5 ZC3H18 SMC5 CCNL1 THRAP3	2.58e-04	209	120	7	int:DEK
Interaction	H2BC13 interactions	PCLO BAZ1B SMC5 SCAF1 ZNF469 KMT2A SRRM2	2.66e-04	210	120	7	int:H2BC13
Interaction	DAXX interactions	SETD1A SETD1B BAZ1B ZC3H18 KAT7 MLLT3 SRRM2 SPEN PML	2.66e-04	353	120	9	int:DAXX
Interaction	BOD1L1 interactions	SETD1A SETD1B GTSE1 WDR5 SMC5 KMT2A	2.70e-04	149	120	6	int:BOD1L1
Interaction	RTF1 interactions	SETD1B KAT6A WDR5 ZC3H18 KMT2A SRRM2	2.80e-04	150	120	6	int:RTF1
Interaction	PYHIN1 interactions	TCF20 LARP1 BAZ1B ZC3H18 SCAF1 SAFB2 SRRM2 SPEN PML	2.95e-04	358	120	9	int:PYHIN1
Interaction	PAXIP1 interactions	SETD1A SETD1B LARP1 WDR5 CCDC88A KMT2A SRRM2 THRAP3 PML	3.01e-04	359	120	9	int:PAXIP1
Interaction	PIP4K2A interactions	SETD1B LARP1 WDR5 ACIN1 MLLT3 SRRM2 SPEN	3.15e-04	216	120	7	int:PIP4K2A
Interaction	RBBP6 interactions	FMR1 ZC3H18 SMC5 CPSF1 ACIN1 SRRM2 THRAP3	3.15e-04	216	120	7	int:RBBP6
Interaction	HDAC11 interactions	MYCBP2 BAZ1B ACIN1 SRRM2 THRAP3 PML	3.22e-04	154	120	6	int:HDAC11
Interaction	YWHAB interactions	RALGAPA1 RAP1GAP ABL2 MYCBP2 KAT6A LARP1 FAM117B PFKFB3 MAST2 PHLDB1 CCDC88A STARD9 KMT2A SRRM2 WDR62 ARAP2	3.39e-04	1014	120	16	int:YWHAB
Interaction	SRPK2 interactions	FMR1 MYCBP2 KAT6A WDR5 ZC3H18 MAST2 SCAF1 PHLDB1 ACIN1 MYO18B SRRM2 SPEN THRAP3	3.48e-04	717	120	13	int:SRPK2
Interaction	NUCKS1 interactions	TCF20 KAT6A BAZ1B CC2D1B WDR5 KAT7 KMT2A	3.52e-04	220	120	7	int:NUCKS1
Interaction	PRPF3 interactions	KAT6A ZC3H18 SMC5 CPSF1 SRRM2 SPEN THRAP3 PML	3.57e-04	291	120	8	int:PRPF3
Interaction	HNRNPUL2 interactions	KAT6A LARP1 WDR5 ZC3H18 SAFB2 ACIN1 IRF2BPL SRRM2	3.57e-04	291	120	8	int:HNRNPUL2
Interaction	EIF4E interactions	FMR1 LARP1 WDR5 ASXL3 CPSF1 EMX2 PML	3.62e-04	221	120	7	int:EIF4E
Interaction	BCL11A interactions	CDCA3 FMR1 NFAM1 BCL11B MTA3	3.62e-04	102	120	5	int:BCL11A
Interaction	SALL1 interactions	BAZ1B SMC5 SALL1 MTA3 CPSF1	3.62e-04	102	120	5	int:SALL1
Interaction	H2AZ1 interactions	TCF20 KAT6A BAZ1B NCK1 WDR5 ZC3H18 SMC5 KAT7 THRAP3	3.83e-04	371	120	9	int:H2AZ1
Interaction	SYMPK interactions	KAT6A WDR5 SMC5 SCAF1 CPSF1 KMT2A PML	4.03e-04	225	120	7	int:SYMPK
Interaction	CEBPA interactions	TCF20 MYCBP2 LARP1 WDR5 ZNF217 LIG1 PRAM1 MTA3 ZBTB40 SAFB2 C1orf52 KMT2A ACIN1 SRRM2 SPEN THRAP3 PML RAD23A	4.06e-04	1245	120	18	int:CEBPA
Interaction	TOP3B interactions	SETD1A SETD1B FMR1 MYCBP2 GTSE1 LAD1 KAT6A INTS1 MAST2 REXO1 PIKFYVE SCAF1 PHLDB1 SIRT2 SAFB2 CPSF1 ACIN1 ZFYVE26 SPEN BAHCC1	4.13e-04	1470	120	20	int:TOP3B
Interaction	FGFR4 interactions	CDCA3 EHBP1 ABL2 NCK1 BICD1 PHLDB1 MTA3 EFR3B ROBO1 SMCR8	4.17e-04	458	120	10	int:FGFR4
Interaction	NFIX interactions	SETD1A ZNF217 SKI SALL1 ZBTB40 KMT2A SPEN	4.25e-04	227	120	7	int:NFIX
Interaction	CDK12 interactions	KAT6A BAZ1B ZC3H18 SMC5 SRRM2 SPEN THRAP3	4.36e-04	228	120	7	int:CDK12
Interaction	SRSF4 interactions	LARP1 ZC3H18 SMC5 SCAF1 KMT2A ACIN1 SRRM2 THRAP3	4.37e-04	300	120	8	int:SRSF4
Interaction	RAPGEF5 interactions	RALGAPA1 NCK1 CCDC88A ZNHIT2	4.51e-04	60	120	4	int:RAPGEF5
Interaction	YWHAE interactions	RALGAPA1 RAP1GAP ABL2 MYCBP2 GTSE1 LARP1 FAM117B ZC3H18 SMC5 MAST2 SHROOM2 PHLDB1 CCDC88A KMT2A SRRM2 WDR62 ARAP2 RAD23A	4.51e-04	1256	120	18	int:YWHAE
Interaction	CSNK1A1 interactions	MYCBP2 GTSE1 KAT6A LARP1 WDR5 ZC3H18 ZNF217 LIG1 CPSF1	4.64e-04	381	120	9	int:CSNK1A1
Interaction	RBM14 interactions	FMR1 GTSE1 WDR5 ZC3H18 SMC5 ZC3H4 SAFB2 AUTS2 CPSF1 ACIN1 THRAP3	4.70e-04	553	120	11	int:RBM14
Interaction	C1orf35 interactions	FMR1 KAT6A ZC3H18 SMC5 CCNL1 ACIN1 SRRM2 PML	4.77e-04	304	120	8	int:C1orf35
Interaction	RPS7 interactions	TCF20 KAT6A NACA WDR5 ZC3H18 SMC5 CCDC88A ASXL3 SRRM2 PML	4.77e-04	466	120	10	int:RPS7
Interaction	BUB3 interactions	SETD1A SETD1B WDR5 ZC3H18 ASXL3 KMT2A PML	4.84e-04	232	120	7	int:BUB3
Interaction	SMARCC1 interactions	MYCBP2 BAZ1B CFP WDR5 NCAPH2 SMC5 MESD KMT2A SRRM2	4.91e-04	384	120	9	int:SMARCC1
Interaction	PPP1CB interactions	MYCBP2 INTS1 LARP1 WDR5 LIG1 SIRT2 CSRNP2 SAFB2 CPSF1 PML	5.02e-04	469	120	10	int:PPP1CB
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETD1A SETD1B KMT2A	3.60e-04	34	74	3	487
GeneFamily	RNA binding motif containing	SETD1A SETD1B ALKBH8 SAFB2 SPEN	1.80e-03	213	74	5	725
GeneFamily	Zinc fingers C2HC-type\|PHD finger proteins\|Lysine acetyltransferases	KAT6A KAT7	1.91e-03	16	74	2	66
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	KAT6A KAT7	2.16e-03	17	74	2	486
GeneFamily	EF-hand domain containing\|Nucleotide excision repair\|Transcription and export complex 2	LIG1 RAD23A	2.42e-03	18	74	2	1269
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	SETD1A INTS1 LARP1 BAZ1B CC2D1B REXO1 SCAF1 SAFB2 ACIN1 SRRM2	3.69e-06	338	120	10	M17094
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	FAM117B BICD1 BCL11B ASXL3 AUTS2 ROBO1 IRF2BPL EMX2 SRRM3 PLXNA2 CXADR	9.96e-06	465	120	11	M39066
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	KAT6A BAZ1B NCK1 ZNF217 SMC5 PIKFYVE ZC3H4 AUTS2 SPEN	1.03e-05	300	120	9	M8702
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	RALGAPA1 BAZ1B MAST2 KAT7 PRCC ZBTB40 ARAP2	1.98e-05	180	120	7	M8239
Coexpression	TOMLINS_PROSTATE_CANCER_UP	NACA ZNF217 BICD1 CXADR	3.36e-05	40	120	4	M19148
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN	PDE4C SETD1B INTS1 PFKFB3 REXO1 NRBP2 CCNL1 ZBTB40 SAFB2 CPSF1 SRRM2 SPEN	3.54e-05	634	120	12	M40866
Coexpression	GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN	FMR1 MYCBP2 ZNF469 CCDC88A MTA3 KMT2A SRRM2	3.90e-05	200	120	7	M8052
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	RALGAPA1 MYCBP2 SKI SAFB2 AUTS2 ACIN1 SLC4A4	4.70e-05	206	120	7	M2817
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	RALGAPA1 MIS18BP1 FMR1 MYCBP2 PAXX KAT6A BAZ1B ZNF217 SKI SMC5 PIKFYVE BCL11B CCDC88A CCNL1 AUTS2 KMT2A SPEN THRAP3 ARAP2	4.76e-05	1492	120	19	M40023
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	RALGAPA1 MYCBP2 SKI SAFB2 AUTS2 ACIN1 SLC4A4	4.99e-05	208	120	7	MM581
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	PDE4C PAXX INTS1 PFKFB3 REXO1 PRAM1 NRBP2 CCNL1 ZBTB40 SAFB2 CPSF1 ZFYVE26 SRRM2 SPEN	6.97e-05	905	120	14	M40865
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000	TCF20 ANKRD6 BCL11B SALL1 ASXL3 ROBO1 MLLT3 CXADR	1.32e-05	196	117	8	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	RALGAPA1 MIS18BP1 TCF20 BAZ1B FAM117B ANKRD6 SMC5 MAST2 PIKFYVE CCDC88A FAM193A SAFB2 MLLT3 EMX2 PLXNA2	2.54e-05	780	117	15	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	GTSE1 LARP1 BAZ1B CCDC88A CCNL1 CPSF1 KMT2A SRRM2 WDR62	2.91e-09	192	121	9	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	ASK452-Endothelial-Lymphatic\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	PDE4C ABI3BP WDR5 BICD1 STARD9 IRF2BPL C1QTNF5 SLC24A1	2.89e-08	176	121	8	b4d280ecc07701d526f50d44c45ea91b3eeb00b1
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 KAT6A BAZ1B CCDC88A CCNL1 KMT2A THRAP3	7.27e-07	184	121	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	ASK452-Endothelial-Lymphatic\|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq	PDE4C ABI3BP WDR5 BICD1 STARD9 IRF2BPL SLC24A1	1.07e-06	195	121	7	20f492299a684ac1b7dd1bbc36a533cd6f9a1c93
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RALGAPA1 ANKRD6 MAST2 RAD51AP2 PER3 EFR3B	5.82e-06	164	121	6	b895674ed2df87db8fbfb30b7e31620945588491
ToppCell	Control-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	ABL2 MYRIP PFKFB3 C4orf54 ROBO1 ARAP2	1.23e-05	187	121	6	5429ae85942b8ec3895cceb63c663de3c24ca064
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDCA3 PDE4C MIS18BP1 GTSE1 CCDC88A WDR62	1.47e-05	193	121	6	e45ce9cf8421512b57f157c24b64793b47b4ba4b
ToppCell	medial-Hematologic-Nonclassical_Monocyte\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PLB1 MIS18BP1 CFP FAM117B NFAM1 PRAM1	1.51e-05	194	121	6	ac203d388a3a3884e316dec0dcbd408e43c6ef6c
ToppCell	medial-2-Hematologic-Nonclassical_Monocyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PLB1 MIS18BP1 CFP FAM117B NFAM1 PRAM1	1.51e-05	194	121	6	202e5070728191c46161fa7d931f00be1c7559d4
ToppCell	medial-Hematologic-Nonclassical_Monocyte-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PLB1 MIS18BP1 CFP FAM117B NFAM1 PRAM1	1.51e-05	194	121	6	002cd317732fc6b0d9a72fb46199f71db5a638a7
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	BCL11B AUTS2 KMT2A SLC4A4 SRRM2 ARAP2	1.65e-05	197	121	6	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	C3orf20 BCL11B CCNL1 KMT2A MLLT3 ARAP2	1.65e-05	197	121	6	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDCA3 MIS18BP1 GTSE1 NCAPH2 CCDC88A WDR62	1.65e-05	197	121	6	d669d90c3f9e98b41bcbc49dbdc5698e0b42597c
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	PCLO BCL11B AUTS2 MLLT3 SRRM3 CXADR	1.70e-05	198	121	6	076c862f2a723f0361749377561cae902068b1a0
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	MYCBP2 PCLO BCL11B SRRM3 PLXNA2 CXADR	1.75e-05	199	121	6	77b4aa00f14b86ef5db0490be98787e063979541
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYCBP2 CCNL1 KMT2A ACIN1 SRRM2 ARAP2	1.80e-05	200	121	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal\|3m / Sample Type, Dataset, Time_group, and Cell type.	PCLO BCL11B AUTS2 MLLT3 PLXNA2 CXADR	1.80e-05	200	121	6	af99d90070e2933fd2e9512590c6cf3bd6e15539
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	PCLO PFKFB3 CCDC88A ASXL3 AUTS2 CXADR	1.80e-05	200	121	6	f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	PCLO CCDC88A ASXL3 AUTS2 SRRM3 CXADR	1.80e-05	200	121	6	68c90376e2779434e4ad8dc6dd3b44baa700e2f4
ToppCell	primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CDCA3 MIS18BP1 GTSE1 ZNF488 WDR62	2.73e-05	129	121	5	ff74d159034a09f7b174da18bfb9a26936252b4c
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Myeloid-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CC2D1B CFP NFAM1 ZC3H4 SLC24A1	4.93e-05	146	121	5	69cbe8d4772f8e46a5e1a1cdca0e370308a97b4f
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	LAD1 ZNF469 PHLDB1 SIRT2 ZNF488	5.61e-05	150	121	5	70ac8ae4b1683fb17278a8e4606f2fa0b94988c0
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAST2 BICD1 ZNF469 SRRM3 PLXNA2	6.55e-05	155	121	5	d76a0f99ec35560d18820f9c92b69364ef2250e3
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	NT5C1B PHLDB1 ROBO1 MLLT3 PLXNA2	6.55e-05	155	121	5	1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	RALGAPA1 KAT6A NT5C1B BCL11B ARAP2	8.08e-05	162	121	5	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	droplet-Lung-nan-3m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE4C LAD1 PFKFB3 BICD1 EFR3B	8.56e-05	164	121	5	78de403446fe0eb375c82ff1832cc5fbb8e20afa
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CDCA3 LAD1 PHLDB1 SIRT2 ZNF488	9.06e-05	166	121	5	a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|356C / Donor, Lineage, Cell class and subclass (all cells)	ABI3BP INTS1 ALKBH8 ZC3H4 STARD9	9.06e-05	166	121	5	c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDCA3 MIS18BP1 GTSE1 LIG1 WDR62	9.32e-05	167	121	5	50c29ea660bf07b890e4ac1a1985d0761d863dee
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE4C ANKRD6 TTBK1 EFR3B SLC4A4	9.59e-05	168	121	5	04a7810f95196a21325356b42084f96c11af5964
ToppCell	facs-Marrow-KLS-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDCA3 LAD1 CFP ANKRD53 CCDC88A	9.86e-05	169	121	5	d6ad3b637de2935c656aad47ad82d6e8a8bd1227
ToppCell	facs-Marrow-KLS-24m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDCA3 LAD1 CFP ANKRD53 CCDC88A	9.86e-05	169	121	5	60ef186518d0dc63dbded2a77c65cfe3129df754
ToppCell	Smart-seq2-blood_(Smart-seq2)\|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MIS18BP1 ADAMTS2 PRAM1 CCDC88A SRRM2	9.86e-05	169	121	5	0ee74cc97a2db9cc16dc73424f74747afe13af90
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP BCL11B SALL1 ROBO1 IRF2BPL	1.04e-04	171	121	5	6f49537f8d3cf18e65aa999fec32ed347ce2da3e
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RALGAPA1 KAT6A BCL11B CCNL1 ARAP2	1.04e-04	171	121	5	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP BCL11B SALL1 ROBO1 IRF2BPL	1.04e-04	171	121	5	ab97ae2b127a585f170f028f1c475cdd1b0cdea5
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ABI3BP INTS1 ALKBH8 ZC3H4 STARD9	1.07e-04	172	121	5	a9e13aa36087170dadca421ba9de588e5a1cf715
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK\|bone_marrow / Manually curated celltypes from each tissue	CDCA3 GTSE1 NCAPH2 LIG1 WDR62	1.10e-04	173	121	5	8a9dd85f718564c07cf3120ad648daeb60c94fc5
ToppCell	wk_20-22-Hematologic-Myeloid-Promonocyte-like\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	GTSE1 CFP NFAM1 PRAM1 WDR62	1.16e-04	175	121	5	654299df246debe0a5b12f0d9568eb828bb94bb9
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ABI3BP INTS1 ALKBH8 ZC3H4 STARD9	1.16e-04	175	121	5	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	CDCA3 PCLO GTSE1 LIG1 WDR62	1.16e-04	175	121	5	fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|368C / Donor, Lineage, Cell class and subclass (all cells)	CDCA3 PCLO GTSE1 LIG1 WDR62	1.16e-04	175	121	5	36c140540497bbe1c5f08fac2d94f08cac18fabb
ToppCell	facs-Heart-RA-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 CCNL1 IRF2BPL SRRM2 THRAP3	1.26e-04	178	121	5	b505e2550860e777535ee95f29c936242fd607f1
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADAMTS2 RIMBP3 BCL11B RIMBP3C RIMBP3B	1.26e-04	178	121	5	39889db130216655a34796e7030ffeb372465500
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RAD51AP2 KANK4 AUTS2 SLC4A4 CXADR	1.29e-04	179	121	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP ABI3BP ADAMTS2 PHLDB1 CXADR	1.36e-04	181	121	5	35eefd874a892eaf21f24fdce89e7ea3b8ee285f
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP ABI3BP ADAMTS2 PHLDB1 CXADR	1.36e-04	181	121	5	e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 SMC5 BCL11B CCNL1 ARAP2	1.39e-04	182	121	5	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 SMC5 BCL11B CCNL1 ARAP2	1.39e-04	182	121	5	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO ASXL3 ROBO1 ZNF488 SLC4A4	1.47e-04	184	121	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ABL2 ABI3BP MYCBP2 ANKRD6 ROBO1	1.47e-04	184	121	5	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO ASXL3 ROBO1 ZNF488 SLC4A4	1.47e-04	184	121	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO ASXL3 ROBO1 ZNF488 SLC4A4	1.47e-04	184	121	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDCA3 MIS18BP1 PCLO GTSE1 LIG1	1.47e-04	184	121	5	16aa8e88bdd51b1d132d5cf33c29963b384a8bae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDCA3 MIS18BP1 GTSE1 EFR3B WDR62	1.58e-04	187	121	5	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RALGAPA1 CCNL1 KMT2A SPEN ARAP2	1.62e-04	188	121	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PI16 MYRIP STPG4 EFR3B KANK4	1.62e-04	188	121	5	ec0e241de2c8310b4417b9d4e2420d7a1662f1c0
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RALGAPA1 BCL11B CCNL1 KMT2A ARAP2	1.79e-04	192	121	5	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	Monocytes-Inflammatory_CD16+_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CFP NFAM1 PRAM1 CCDC88A KNDC1	1.79e-04	192	121	5	4be5c2c946337cd3e710137726358adca563f146
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADAMTS2 PFKFB3 NFAM1 PRAM1 CCDC88A	1.83e-04	193	121	5	5f732598cdb6f3bd519f044a9cc553bd2e8b1052
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MIS18BP1 ADAMTS2 PRAM1 CCDC88A SRRM2	1.83e-04	193	121	5	1db487e5f81849740d57cc3e2b5739e8f7581efb
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CDCA3 MIS18BP1 GTSE1 LIG1 WDR62	1.83e-04	193	121	5	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	LA\|World / Chamber and Cluster_Paper	EHBP1 ABI3BP PI16 BICD1 ROBO1	1.83e-04	193	121	5	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-suprabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM117B PHLDB1 PLXNA2 WDR62 ARAP2	1.88e-04	194	121	5	a3adcdc8b87332e8beb9bcd70cf36424af10633d
ToppCell	COPD-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	ABL2 MYRIP PFKFB3 ROBO1 ARAP2	1.88e-04	194	121	5	8dcde77767b23e75360adb316cdccf56a00e3726
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	ABI3BP ADAMTS2 PI16 PHLDB1 ROBO1	1.88e-04	194	121	5	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MIS18BP1 ADAMTS2 PRAM1 CCDC88A SRRM2	1.88e-04	194	121	5	a94f9f7179a5733e3c378ff8b337e288785433a1
ToppCell	COVID-19_Convalescent-PLT_4\|COVID-19_Convalescent / Disease Group and Platelet Clusters	MIS18BP1 NACA NCK1 BICD1 CCNL1	1.88e-04	194	121	5	ce1fad4e76a87f0c35e430ed1f2262395df882fd
ToppCell	distal-2-Hematologic-Nonclassical_Monocyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MIS18BP1 CFP FAM117B NFAM1 PRAM1	1.92e-04	195	121	5	34bed73e4dae34b0f1076b7ff9dc7ea2096c1796
ToppCell	E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ABI3BP ROBO1 MLLT3 IRF2BPL PLXNA2	1.92e-04	195	121	5	1daddd801bd4596fffbdb822fc326d5127c96004
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	EHBP1 ABI3BP PI16 PHLDB1 ROBO1	1.92e-04	195	121	5	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	severe-Classical_Monocyte\|World / disease stage, cell group and cell class	ADAMTS2 CFP PFKFB3 PRAM1 CCDC88A	1.92e-04	195	121	5	cf638aac4d57ae0774008920a1a5e9dfd8c73885
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	CDCA3 GTSE1 LIG1 BCL11B WDR62	1.92e-04	195	121	5	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 PCLO RAD51AP2 KMT2A SRRM2	1.92e-04	195	121	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 PCLO RAD51AP2 KMT2A SRRM2	1.92e-04	195	121	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LAD1 C4orf54 SIRT2 KANK4 ZNF488	1.92e-04	195	121	5	80b973d2a23ef9b101c90e1635e68c9a3f78f65d
ToppCell	cellseq-Immune-Immune_Myeloid-iMON\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADAMTS2 CFP PFKFB3 NFAM1 PRAM1	1.97e-04	196	121	5	5842d6fa0c066815d7d8c7e59b192bfc72960707
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	NACA BICD1 AUTS2 MLLT3 PLXNA2	1.97e-04	196	121	5	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	CDCA3 MIS18BP1 GTSE1 SALL1 WDR62	1.97e-04	196	121	5	5905f0e3061a6b98b7a33d64c782c3dda2cd51ef
ToppCell	Adult-Immune-monocyte-D122\|Adult / Lineage, Cell type, age group and donor	PLB1 ADAMTS2 CFP NFAM1 PRAM1	1.97e-04	196	121	5	16b0acb6157534938ca83d4e909471e33a7d3c52
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	NACA BICD1 AUTS2 MLLT3 PLXNA2	1.97e-04	196	121	5	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	cellseq-Immune-Immune_Myeloid-iMON-iMON\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADAMTS2 CFP PFKFB3 NFAM1 PRAM1	1.97e-04	196	121	5	8608be3c3e7fd776c5f2fae207cd0b801e138349
ToppCell	Children_(3_yrs)-Immune-monocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTS2 CFP NFAM1 PRAM1 CCDC88A	1.97e-04	196	121	5	cacd69be72e6167814f7adea7c5fa114f3103bbb
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ABI3BP ADAMTS2 SMC5 PHLDB1 ROBO1	1.97e-04	196	121	5	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADAMTS2 CFP PFKFB3 NFAM1 PRAM1	2.02e-04	197	121	5	a1d42d0177630e08f36a96a6272f796244c1a319
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADAMTS2 CFP PFKFB3 NFAM1 PRAM1	2.02e-04	197	121	5	bb0d814d88a14199eb8ab2b3bd67511b19e3ab5d
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-PNs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	PCLO AUTS2 MLLT3 PLXNA2 CXADR	2.02e-04	197	121	5	10e72b425a2bcba35e63a5b074d3dedcd49a762e
ToppCell	severe-Classical_Monocyte\|severe / disease stage, cell group and cell class	ADAMTS2 CFP PFKFB3 PRAM1 CCDC88A	2.02e-04	197	121	5	1263f141fd03a9294127ab5572893f7ae8b49230
ToppCell	Control-Stromal-Fibroblast\|Stromal / Disease state, Lineage and Cell class	ABL2 ABI3BP PI16 CCNL1 AUTS2	2.02e-04	197	121	5	64cc5f61c88e9560b0f8f6f3151255dffb5c3d66
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	BICD1 BCL11B AUTS2 EMX2 PLXNA2	2.06e-04	198	121	5	6d12ecaa9532c134d9c4562534dcb59a6420b4d3
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	BICD1 BCL11B AUTS2 EMX2 PLXNA2	2.06e-04	198	121	5	7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes\|lymph-node_spleen / Manually curated celltypes from each tissue	ADAMTS2 CFP NFAM1 PRAM1 CCDC88A	2.06e-04	198	121	5	187a04d498f0b355cb11c81172721698818082d6
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	CDCA3 MIS18BP1 GTSE1 EMX2 WDR62	2.06e-04	198	121	5	dada1c19a261c8e1090957cd7e37f2a43a9fe14f
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Monocytic\|lymph-node_spleen / Manually curated celltypes from each tissue	ADAMTS2 CFP NFAM1 PRAM1 CCDC88A	2.06e-04	198	121	5	065c8a9655d19f93dfdb453c78bbfe7d857caf3e
ToppCell	mLN-T_cell-cycling_gd_T\|T_cell / Region, Cell class and subclass	CDCA3 PCLO GTSE1 WDR62 CFAP46	2.11e-04	199	121	5	c81a194f8c2f120c6c4d74857912865a3c2fe1e7
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	CDCA3 MIS18BP1 GTSE1 LIG1 WDR62	2.11e-04	199	121	5	a99516a5760f49a69b0fe45a9b2316e393252966
ToppCell	Neuron\|World / Primary Cells by Cluster	PCLO ASXL3 AUTS2 MLLT3 CXADR	2.11e-04	199	121	5	1f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCell	Neuron-Postmitotic\|World / Primary Cells by Cluster	PCLO ASXL3 AUTS2 MLLT3 CXADR	2.11e-04	199	121	5	1973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	FAM117B BCL11B MLLT3 PLXNA2 CXADR	2.11e-04	199	121	5	a255484ba77bd2741a541da278efc8cf4abbe570
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	PCLO BCL11B MLLT3 PLXNA2 CXADR	2.16e-04	200	121	5	84e4565d28a02700bf7f6730d1b3a58744ca0aea
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	EHBP1 MIS18BP1 MYCBP2 PCLO GTSE1 SKI SMC5 CCDC88A KMT2A SRRM2 SPEN	2.07e-09	178	117	11	3998_DN
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	RALGAPA1 EHBP1 MIS18BP1 ABI3BP GTSE1 CCDC88A KMT2A SLC24A1 SPEN	7.35e-07	194	117	9	4312_DN
Drug	colchicine; Down 200; 1uM; SKMEL5; HG-U133A	LIG1 PHLDB1 CCDC88A ZBTB40 CPSF1 KMT2A ACIN1 PML BAHCC1	7.67e-07	195	117	9	630_DN
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A	RALGAPA1 KAT6A BAZ1B SKI SIRT2 AUTS2 SPEN PML BAHCC1	8.36e-07	197	117	9	2259_DN
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	KAT6A NACA MYRIP NCAPH2 CCNL1 ZBTB40 KMT2A SLC24A1	3.33e-06	174	117	8	6048_UP
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	EHBP1 MIS18BP1 MYCBP2 GTSE1 SMC5 KMT2A SRRM2 SPEN	4.10e-06	179	117	8	4585_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	RALGAPA1 EHBP1 MIS18BP1 KAT6A BAZ1B BICD1 ZBTB40 SPEN	6.13e-06	189	117	8	4304_DN
Drug	Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; HL60; HT_HG-U133A	RALGAPA1 NCAPH2 SKI STS SLC24A1 WDR62 PML BAHCC1	6.37e-06	190	117	8	2456_DN
Drug	Leflunomide [75706-12-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ABI3BP KAT6A SKI PHLDB1 IQCC SLC24A1 PML BAHCC1	6.88e-06	192	117	8	6102_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	EHBP1 MIS18BP1 KAT6A NCAPH2 BICD1 CCDC88A STS SPEN	7.42e-06	194	117	8	4320_DN
Drug	Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A	EHBP1 MIS18BP1 NCAPH2 CCDC88A ZBTB40 KMT2A SRRM2 PML	7.71e-06	195	117	8	6159_DN
Drug	Finasteride [98319-26-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	PCLO NCAPH2 MAST2 CCDC88A ZBTB40 KMT2A SLC4A4 PML	8.00e-06	196	117	8	4766_DN
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A	SETD1A NCAPH2 SIRT2 IQCC SRRM2 ZNHIT2 PML RAD23A	8.00e-06	196	117	8	6559_UP
Drug	Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A	KAT6A BAZ1B NCAPH2 ZBTB40 SLC24A1 SRRM2 SPEN PML	8.30e-06	197	117	8	4556_DN
Drug	Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	EHBP1 NCAPH2 STS SLC41A3 SAFB2 MLLT3 WDR62 PML	8.30e-06	197	117	8	1691_UP
Drug	Tiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A	ABL2 BAZ1B ANKRD6 STS SLC24A1 SRRM2 WDR62 PML	8.30e-06	197	117	8	7311_UP
Drug	Methocarbamol [532-03-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A	RALGAPA1 ABI3BP KAT6A BAZ1B SKI ZBTB40 SLC4A4 PML	8.62e-06	198	117	8	2274_DN
Drug	Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A	RALGAPA1 SETD1A BAZ1B ANKRD6 SKI ZBTB40 PML BAHCC1	8.94e-06	199	117	8	2257_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; HL60; HT_HG-U133A	SETD1A PCLO BAZ1B SKI STS CSRNP2 SAFB2 MLLT3	8.94e-06	199	117	8	3067_DN
Drug	Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; MCF7; HT_HG-U133A	NCAPH2 BICD1 STS PER3 IQCC AUTS2 SLC4A4 PML	9.27e-06	200	117	8	7329_UP
Drug	Trapidil [15421-84-8]; Down 200; 19.4uM; MCF7; HT_HG-U133A	BAZ1B NCAPH2 PHLDB1 ZBTB40 SAFB2 ZNHIT2 WDR62 PML	9.27e-06	200	117	8	7475_DN
Drug	chrysene	EHBP1 SETD1B FMR1 ABI3BP PFKFB3 NRBP2 PER3 CCNL1 SAFB2 KANK4 ACIN1 ROBO1 IRF2BPL SRRM2 THRAP3	4.06e-05	871	117	15	ctd:C031180
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A	EHBP1 GTSE1 ZBTB40 KMT2A MLLT3 SRRM2 SPEN	4.55e-05	183	117	7	1709_DN
Drug	Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	SETD1A RAP1GAP PCLO NCAPH2 PFKFB3 WDR62 PML	4.88e-05	185	117	7	6243_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A	EHBP1 KAT6A BICD1 BCL11B CCDC88A STS KMT2A	5.22e-05	187	117	7	4323_DN
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A	EHBP1 MIS18BP1 KAT6A BAZ1B CCDC88A STS SPEN	5.40e-05	188	117	7	4310_DN
Drug	Pregnenolone [145-13-1]; Down 200; 12.6uM; HL60; HT_HG-U133A	LAD1 NCAPH2 MAST2 IQCC SAFB2 WDR62 PML	5.58e-05	189	117	7	2497_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	MIS18BP1 ABI3BP KAT6A SKI SMC5 BICD1 CCDC88A	5.97e-05	191	117	7	4279_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	RALGAPA1 MIS18BP1 KAT6A BAZ1B NCAPH2 CCDC88A SPEN	5.97e-05	191	117	7	4283_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	EHBP1 MIS18BP1 ABI3BP GTSE1 BAZ1B BCL11B KMT2A	5.97e-05	191	117	7	6020_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	EHBP1 MIS18BP1 KAT6A SKI STS KMT2A PML	5.97e-05	191	117	7	6644_DN
Drug	daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A	MIS18BP1 BICD1 PER3 MLLT3 SLC24A1 ZNHIT2 WDR62	5.97e-05	191	117	7	7525_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	EHBP1 MIS18BP1 PCLO KAT6A SLC41A3 KMT2A ZNHIT2	6.17e-05	192	117	7	5058_DN
Drug	Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A	EHBP1 MIS18BP1 BAZ1B BCL11B CCDC88A SPEN PML	6.37e-05	193	117	7	4321_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ABL2 GTSE1 KAT6A NCAPH2 SKI SLC24A1 PML	6.37e-05	193	117	7	4406_DN
Drug	Cefixime [79350-37-1]; Down 200; 8.8uM; HL60; HT_HG-U133A	BAZ1B CCDC88A SAFB2 MLLT3 SLC4A4 SLC24A1 ARAP2	6.58e-05	194	117	7	1310_DN
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A	SETD1A PDE4C ABL2 ABI3BP NCAPH2 STS SLC24A1	7.02e-05	196	117	7	5279_DN
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A	BAZ1B NCAPH2 SKI BICD1 SLC4A4 SRRM2 WDR62	7.02e-05	196	117	7	5523_DN
Drug	Diazoxide [364-98-7]; Up 200; 17.4uM; PC3; HT_HG-U133A	EHBP1 SETD1B BAZ1B BICD1 STS PER3 SLC41A3	7.02e-05	196	117	7	2052_UP
Drug	Metrizamide [31112-62-6]; Up 200; 5uM; MCF7; HT_HG-U133A	ABL2 SETD1B NCAPH2 MAST2 PHLDB1 SAFB2 SLC24A1	7.25e-05	197	117	7	3255_UP
Drug	Hexetidine [141-94-6]; Down 200; 11.8uM; HL60; HT_HG-U133A	NCAPH2 BICD1 STS PER3 ZNHIT2 WDR62 PML	7.25e-05	197	117	7	2457_DN
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; HL60; HT_HG-U133A	LAD1 KAT6A BAZ1B CFP SLC4A4 SRRM2 PML	7.25e-05	197	117	7	2133_DN
Drug	Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A	BAZ1B NCAPH2 PHLDB1 PER3 WDR62 ARAP2 PML	7.25e-05	197	117	7	7476_DN
Drug	Lactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	ABL2 NCAPH2 PHLDB1 BCL11B STS AUTS2 SRRM2	7.25e-05	197	117	7	6605_UP
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	SETD1A KAT6A SKI LIG1 PHLDB1 SLC24A1 SRRM2	7.25e-05	197	117	7	3247_UP
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	SETD1B BAZ1B NCAPH2 CSRNP2 SAFB2 WDR62 ARAP2	7.49e-05	198	117	7	6991_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	KAT6A BAZ1B NCAPH2 STS PER3 AUTS2 BAHCC1	7.49e-05	198	117	7	2320_DN
Drug	Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A	KAT6A BAZ1B SKI SMC5 SIRT2 BCL11B SLC24A1	7.49e-05	198	117	7	7279_UP
Drug	Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; PC3; HT_HG-U133A	ABL2 NCAPH2 KMT2A SLC24A1 WDR62 PML BAHCC1	7.49e-05	198	117	7	5102_UP
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	BAZ1B MAST2 ZBTB40 SLC4A4 WDR62 PML BAHCC1	7.49e-05	198	117	7	2251_DN
Drug	Chlorpropamide [94-20-2]; Up 200; 14.4uM; PC3; HT_HG-U133A	SETD1A ABL2 PHLDB1 BCL11B CCDC88A SAFB2 MLLT3	7.49e-05	198	117	7	6291_UP
Drug	Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A	RALGAPA1 BAZ1B NCAPH2 MAST2 SAFB2 AUTS2 PML	7.49e-05	198	117	7	6841_DN
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A	KAT6A ANKRD6 STS AUTS2 ROBO1 SRRM2 BAHCC1	7.73e-05	199	117	7	2319_DN
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	RALGAPA1 NCAPH2 MAST2 SIRT2 STS MLLT3 BAHCC1	7.73e-05	199	117	7	4523_DN
Drug	Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; PC3; HT_HG-U133A	LAD1 PHLDB1 SAFB2 KMT2A MLLT3 SRRM2 BAHCC1	7.73e-05	199	117	7	7284_DN
Drug	Thiocolchicoside [602-41-5]; Down 200; 7uM; PC3; HT_HG-U133A	BAZ1B MAST2 BICD1 PHLDB1 SAFB2 SLC4A4 BAHCC1	7.73e-05	199	117	7	5095_DN
Drug	Sulfanilamide [63-74-1]; Up 200; 23.2uM; MCF7; HT_HG-U133A	ABL2 NCAPH2 MAST2 BICD1 KMT2A WDR62 PML	7.73e-05	199	117	7	3449_UP
Drug	estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A	ANKRD6 BICD1 SAFB2 SLC4A4 SRRM2 PML BAHCC1	7.73e-05	199	117	7	1633_UP
Drug	2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A	RALGAPA1 NCAPH2 MAST2 BICD1 PHLDB1 PER3 SLC4A4	7.97e-05	200	117	7	5750_DN
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	KAT6A NCAPH2 SKI MAST2 BCL11B PER3 PML	7.97e-05	200	117	7	2323_DN
Drug	benz(a)anthracene	EHBP1 RAP1GAP SETD1B FMR1 ABI3BP PCLO PFKFB3 NRBP2 PER3 CCNL1 KANK4 ACIN1 IRF2BPL SRRM2 THRAP3 PLXNA2 ARAP2	2.22e-04	1251	117	17	ctd:C030935
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	NACA CCNL1 ZBTB40 KMT2A SPEN PML	2.27e-04	167	117	6	6047_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SETD1B LAD1 LARP1 SRRM2 ZNHIT2 ARAP2	2.35e-04	168	117	6	6820_DN
Drug	In-G	SETD1A KAT6A WDR5 KAT7 SIRT2 CXADR	2.50e-04	170	117	6	CID000446054
Drug	Methamphetamine	RALGAPA1 CDCA3 KAT6A BAZ1B CC2D1B MAST2 REXO1 PHLDB1 SIRT2 NRBP2 FAM193A ZNF532 CCNL1 ZBTB40 KNDC1 ACIN1 MYO18B SRRM2	2.84e-04	1401	117	18	ctd:D008694
Drug	Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A	NCAPH2 MAST2 PHLDB1 ZBTB40 SRRM2 WDR62	2.92e-04	175	117	6	3873_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SETD1B BAZ1B ZC3H4 SRRM2 ZNHIT2 ARAP2	3.20e-04	178	117	6	4710_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SETD1B NACA ZC3H4 SLC24A1 SRRM2 QRSL1	3.20e-04	178	117	6	6276_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LARP1 BAZ1B NCAPH2 SRRM2 ZNHIT2 QRSL1	3.40e-04	180	117	6	6454_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	KAT6A NCK1 ZNF217 PFKFB3 ZC3H4 ZBTB40	3.40e-04	180	117	6	4541_DN
Drug	Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A	PCLO KAT6A SKI STS SRRM2 PML	3.61e-04	182	117	6	5010_UP
Drug	17-AAG; Up 200; 1uM; PC3; HT_HG-U133A	ABL2 ABI3BP NACA NCAPH2 SLC24A1 PML	3.71e-04	183	117	6	1206_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	RALGAPA1 SETD1B NACA ZC3H4 SRRM2 QRSL1	3.82e-04	184	117	6	7555_DN
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	NCK1 ZNF217 FAM193A ZC3H4 KMT2A SPEN	3.94e-04	185	117	6	1114_DN
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A	SETD1A KAT6A NCAPH2 PFKFB3 MLLT3 PML	4.05e-04	186	117	6	2426_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	EHBP1 CCDC88A KMT2A SRRM2 SPEN RAD23A	4.17e-04	187	117	6	4302_DN
Drug	Alsterpaullone; Down 200; 10uM; MCF7; HT_HG-U133A	NCK1 ZNF217 PIKFYVE CSRNP2 ZC3H4 CCNL1	4.17e-04	187	117	6	7051_DN
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	PDE4C MIS18BP1 PCLO KAT6A SMC5 KMT2A	4.29e-04	188	117	6	4545_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	EHBP1 MIS18BP1 MYCBP2 SMC5 SRRM2 SPEN	4.41e-04	189	117	6	1045_DN
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	NCAPH2 PFKFB3 BICD1 ZBTB40 WDR62 ARAP2	4.41e-04	189	117	6	6997_DN
Drug	Gramine [87-52-5]; Up 200; 23uM; HL60; HT_HG-U133A	LAD1 NCAPH2 EFR3B KMT2A MLLT3 PML	4.53e-04	190	117	6	2143_UP
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A	EHBP1 KAT6A SKI KMT2A SLC4A4 SPEN	4.53e-04	190	117	6	4507_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	RALGAPA1 EHBP1 MIS18BP1 ABI3BP KAT6A SPEN	4.53e-04	190	117	6	4306_DN
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A	EHBP1 PDE4C KAT6A BAZ1B CCDC88A SPEN	4.53e-04	190	117	6	4307_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	EHBP1 MIS18BP1 KAT6A BAZ1B CCDC88A SPEN	4.66e-04	191	117	6	4303_DN
Drug	lomustine; Down 200; 100uM; MCF7; HT_HG-U133A	BCL11B SAFB2 SLC4A4 SLC24A1 PML BAHCC1	4.66e-04	191	117	6	7045_DN
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A	EHBP1 MIS18BP1 KAT6A CPSF1 KMT2A SPEN	4.66e-04	191	117	6	3926_DN
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	RALGAPA1 SETD1A ABL2 PCLO BAZ1B SRRM2	4.79e-04	192	117	6	2123_UP
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A	EHBP1 KAT6A BAZ1B CCDC88A PER3 SPEN	4.79e-04	192	117	6	4311_DN
Drug	Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A	KAT6A BAZ1B NCAPH2 SKI PHLDB1 BAHCC1	4.92e-04	193	117	6	4146_DN
Drug	Captopril [62571-86-2]; Up 200; 17.2uM; HL60; HG-U133A	RAP1GAP NCAPH2 SMC5 SHROOM2 SAFB2 SLC4A4	4.92e-04	193	117	6	1988_UP
Drug	0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A	PCLO MAST2 PHLDB1 STS SLC24A1 PML	4.92e-04	193	117	6	4712_UP
Drug	Alsterpaullone; Up 200; 10uM; MCF7; HT_HG-U133A	PDE4C INTS1 NCAPH2 MAST2 AUTS2 WDR62	5.06e-04	194	117	6	7051_UP
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A	KAT6A BAZ1B NCAPH2 BICD1 BCL11B CCDC88A	5.06e-04	194	117	6	4319_DN
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A	BAZ1B MAST2 ZBTB40 KMT2A ACIN1 PML	5.06e-04	194	117	6	4524_DN
Drug	H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A	PCLO SMC5 BICD1 KMT2A QRSL1 PLXNA2	5.06e-04	194	117	6	6921_UP
Drug	calmidazolium chloride; Down 200; 5uM; MCF7; HT_HG-U133A_EA	EHBP1 MIS18BP1 GTSE1 SMC5 ROBO1 MLLT3	5.06e-04	194	117	6	906_DN
Drug	Ornidazole [16773-42-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A	KAT6A MAST2 PHLDB1 STS SLC41A3 MLLT3	5.06e-04	194	117	6	5483_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	PDE4C ABI3BP BAZ1B SKI PHLDB1 STS	5.06e-04	194	117	6	3539_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	MIS18BP1 GTSE1 SKI SMC5 KMT2A SRRM2	5.06e-04	194	117	6	4361_DN
Disease	neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology)	SETD1A SETD1B	1.48e-05	2	114	2	DOID:0070417 (implicated_via_orthology)
Disease	Mixed anxiety and depressive disorder	FMR1 PLXNA2	1.48e-05	2	114	2	C0338908
Disease	QRS-T angle	LAD1 NACA KMT2A IRF2BPL MYO18B	5.85e-05	106	114	5	EFO_0020097
Disease	Intellectual Disability	RALGAPA1 SETD1A FMR1 TCF20 BCL11B ALKBH8 ZBTB40 ACIN1 WDR62	6.18e-05	447	114	9	C3714756
Disease	serum gamma-glutamyl transferase measurement	EHBP1 PLB1 PDE4C BAZ1B NCK1 SKI SALL1 KMT2A ROBO1 MLLT3 ARAP2 BAHCC1	2.22e-04	914	114	12	EFO_0004532
Disease	mean reticulocyte volume	SETD1A RAP1GAP ZNF217 NCAPH2 ARMC2 REXO1 HPS3 KAT7 ZNF469 ZBTB40 MLLT3	2.75e-04	799	114	11	EFO_0010701
Disease	cortical thickness	GDF5-AS1 EHBP1 ADAMTS2 MYCBP2 MAST2 ZNF469 PHLDB1 BCL11B CCDC88A AUTS2 KMT2A ROBO1 PLXNA2	3.73e-04	1113	114	13	EFO_0004840
Disease	intermittent Staphylococcus aureus carrier status	ZNF532 ROBO1	5.23e-04	9	114	2	EFO_0007758
Disease	mean arterial pressure	TCF20 PFKFB3 REXO1 TTBK1 EFR3B AUTS2 ROBO1 BAHCC1	7.28e-04	499	114	8	EFO_0006340
Disease	Congenital Abnormality	FMR1 SALL1	7.95e-04	11	114	2	C0000768
Disease	von Willebrand factor measurement, coagulation factor measurement	ANKRD6 SAFB2	9.52e-04	12	114	2	EFO_0004629, EFO_0004634
Disease	5-methyluridine (ribothymidine) measurement	PCLO NCAPH2	1.31e-03	14	114	2	EFO_0020013
Disease	Muscle hypotonia	RALGAPA1 INTS1	1.94e-03	17	114	2	C0026827
Disease	cyclic adenosine monophosphate measurement	NT5C1B ARAP2	1.94e-03	17	114	2	EFO_0010473
Disease	hearing loss	NCAPH2 MAST2 PHLDB1	2.25e-03	67	114	3	EFO_0004238
Disease	reticulocyte count	RAP1GAP LARP1 FAM117B ZNF217 SKI MAST2 PIKFYVE ZNF469 ZC3H4 ZBTB40 THRAP3	2.43e-03	1045	114	11	EFO_0007986
Disease	Osteogenesis imperfecta	MESD PHLDB1	2.96e-03	21	114	2	cv:C0029434
Disease	Precursor B-cell lymphoblastic leukemia	AUTS2 KMT2A	2.96e-03	21	114	2	C1292769
Disease	Malignant neoplasm of breast	EHBP1 RAP1GAP CFP SHROOM2 ALKBH8 PER3 ZNF532 ROBO1 ZFYVE26 SPEN ZNHIT2	2.99e-03	1074	114	11	C0006142
Disease	unipolar depression, bipolar disorder	PCLO NFAM1 STARD9 ASXL3	3.20e-03	156	114	4	EFO_0003761, MONDO_0004985
Disease	dyslexia	SCAF1 BCL11B AUTS2 MYO18B	3.66e-03	162	114	4	EFO_0005424

Protein segments in the cluster

Peptide	Gene	Start	Entry
TKVPSRSPENSLDPK	PI16	326	Q6UXB8
SPSPPRLTEDRKKAS	ACIN1	386	Q9UKV3
RSPSTKAPSIDEPRS	NT5C1B	126	Q96P26
AATKERTESEVPPRP	BARGIN	536	Q6ZT62
TKKVSSEAPPPSEAA	BAHCC1	2056	Q9P281
TPTKAEAEKPAPRRA	DPEP2NB	71	A0A0U1RQF7
APPSSPVLDTSDIRK	BICD1	606	Q96G01
KSEESAAPSRERPKA	ABL2	836	P42684
SQRKETPPSFPESDK	ALKBH8	351	Q96BT7
TPPSFPESDKEASRL	ALKBH8	356	Q96BT7
KRQVSRPAAPDEEPS	CSRNP2	281	Q9H175
STRRSQPKAPPVDDA	BAZ1B	1311	Q9UIG0
PSKRPPISDSEELSA	MLLT3	281	P42568
PDRSLPPSDSKKTVE	ARMC2	146	Q8NEN0
KSSRDPPASRAAPEE	CFAP46	2006	Q8IYW2
QSDDKLSPPKRDFPT	ARAP2	141	Q8WZ64
PEETSRRTPDPAKSA	C1orf52	31	Q8N6N3
PASKPSSPREVKAEE	CCNL1	336	Q9UK58
SRSPRTEESKADSPP	FAM193A	381	P78312
KSSEPSKSPDGIRNE	ASXL3	941	Q9C0F0
SRPDPDSPIRKISSK	ADAMTS2	1046	O95450
ASDSSPPVVRPKEKA	ANKRD6	551	Q9Y2G4
QSSDKPSRDPETPRS	CDCA3	166	Q99618
AELRKPTSSLTPPED	RAD51AP2	11	Q09MP3
PAAREDKSPSEESAP	RAD23A	116	P54725
SLPKASKSEERPSSP	RIMBP3B	301	A6NNM3
SLPKASKSEERPSSP	RIMBP3C	301	A6NJZ7
KPPKGQAPTDRSSRD	IQCC	401	Q4KMZ1
AAEETAVSPRKSPRP	PAXX	141	Q9BUH6
PRADPSPSKESDQTA	ANKRD53	86	Q8N9V6
PSPARPKKSEESRFS	LARP1	566	Q6PKG0
KNTADHDESPPRTPT	KAT7	116	O95251
DAKPAPKRATASEQP	LAD1	276	O00515
KAKTPTPEPFDSETR	NRBP2	406	Q9NSY0
VETDFSTPTPRRKTP	MIS18BP1	1081	Q6P0N0
KRKPSVPDSASPADD	NCK1	81	P16333
SPTAAGTERRKEDTP	SLC24A1	131	O60721
RDSTEAPKPKSSPEQ	INTS1	1316	Q8N201
RPSAPVDFSKIDPSK	MESD	86	Q14696
SPSKEEARRSSQPPA	CPSF1	756	Q10570
TKDSRLPISVDSPPA	CCDC88A	1826	Q3V6T2
LRKRKASPEPPDSAE	IRF2BPL	541	Q9H1B7
DPKPLSPTADESSRA	PCLO	3681	Q9Y6V0
RKKLPEPPDSSSSNT	PER3	741	P56645
PTLSSRKLPRDPESS	PLXNA2	196	O75051
SKIPRSPSDLTNPER	PDE4C	636	Q08493
ESRSPSPLQAPEKEK	EFR3B	211	Q9Y2G0
ASPEPTKKPRINSFE	PFKFB3	466	Q16875
STSSREAEPRKGEPA	AUTS2	956	Q8WXX7
PKETRSRKCSAPEPS	CFP	216	P27918
PASPSRTKIPAEKES	GTSE1	241	Q9NYZ3
RDVKNSPLEPDTSTP	KAT6A	1131	Q92794
SDSRPKSSSPIRLPE	PIKFYVE	1706	Q9Y2I7
ASSRPPPNRTDKEKS	FMR1	446	Q06787
KALDKDSPPPSSRSE	BCL11B	91	Q9C0K0
DSPPPSSRSELRKVS	BCL11B	96	Q9C0K0
FSAKRSESRVPPPSD	C1QTNF5	106	Q9BXJ0
RFKSPQSPKDIDVSP	CYP2A13	461	Q16696
DPRDSTTVHEPINKP	QRSL1	251	Q9H0R6
PEQSRSSPEKRSPSA	FAM117B	181	Q6P1L5
DIREDVPPPKSRTST	CXADR	276	P78310
KDEPESAPVSPVRKT	C3orf20	621	Q8ND61
DPSRPGTERTSSKEA	GDF5-AS1	131	Q5U4N7
RLPEPRASSSKESPS	CC2D1B	516	Q5T0F9
RSDPESPIKKTSLSP	EHBP1	746	Q8NDI1
RTPPPTKRSLSEEKE	MAST2	866	Q6P0Q8
SDRKTPPAGREETSS	KANK4	526	Q5T7N3
PSAREDPAPKKSSSE	KMT2A	1246	Q03164
PESETSRGPRASPTK	KNDC1	246	Q76NI1
VAKDSPLPASRSEDP	EMX2	16	Q04743
SPATRAPPDEVTNRK	C4orf54	1441	D6RIA3
EKEASNSSRETEPPP	LIG1	21	P18858
NSSRETEPPPKAALK	LIG1	26	P18858
SPSIEEKPQRAVPSE	SALL1	941	Q9NSC2
KLSPSPTTEDPRVRS	MTA3	426	Q9BTC8
PTTASTPKARADPEI	REXO1	301	Q8N1G1
DKPSSPSPRVRDKAA	SRRM3	336	A6NNA2
PSPDFKRALDSSPEA	TMEM233	6	B4DJY2
RSPSVSSPEPAEKSR	SRRM2	1726	Q9UQ35
RKPSDGSPDTKPSRL	PRCC	206	Q92733
SKRQPPDTTPLRTSE	HPS3	811	Q969F9
SLPKASKSEERPSSP	RIMBP3	301	Q9UFD9
KASPEAASTPRDPID	PML	401	P29590
KDPTRKCPDPRSASS	NFAM1	196	Q8NET5
KPQSSEPKRDSSAFP	PRAM1	256	Q96QH2
DVEPRDDSSPSPKGR	PRAM1	511	Q96QH2
EKRESPPAGQKTPDS	RAP1GAP	511	P47736
SKDPRERNPLTPASE	STS	506	P08842
IPSPRSTEERKEEPS	SHROOM2	1371	Q13796
KSPPPAKDEARTTER	SIRT2	371	Q8IXJ6
QSVTPKPLETEPSRE	SLC41A3	46	Q96GZ6
RKEPPDTTSSGDQKR	SETD1B	966	Q9UPS6
ELRFASPTPKRPSEN	MYCBP2	2386	O75592
KDATRTPSSADPLAP	STARD9	2706	Q9P2P6
PDKDPSDTVPTSVHR	PLB1	371	Q6P1J6
ASEEKRPRPSTPAEE	SETD1A	906	O15047
SEPPASIRPKTDDTS	SKI	326	P12755
SKPSQDRPPSSSLEE	SMCR8	391	Q8TEV9
SAPKAALEPKESRSP	NCAPH2	271	Q6IBW4
PKEVNDSPRAADKSP	ZNF532	301	Q9HCE3
SAFSKPTKRPAERPE	ZNF488	161	Q96MN9
EKSSSPPPRKTSESR	THRAP3	531	Q9Y2W1
EDTPASEPAAALPRK	TTBK1	1131	Q5TCY1
KEPEPLHSPDSERSS	RALGAPA1	1471	Q6GYQ0
SVEERTPTKASVPPD	SPEN	2416	Q96T58
ESRSPFLKPDERAPT	SCAF1	871	Q9H7N4
SFKDKPRPSPSTLVD	STPG4	116	Q8N801
PSAPSKPEVTDVSRN	ROBO1	561	Q9Y6N7
EAPTEAPSPEARDSK	SAFB2	336	Q14151
TTPDPKLNREVAESP	PHLDB1	476	Q86UU1
IPKRDSSKDLPSPDS	TCF20	1311	Q9UGU0
APTDPRLQKPTDSTA	ZC3H4	1076	Q9UPT8
EQKIREEDKSPPPSS	MYO18B	11	Q8IUG5
SSRTKPTLDETPENP	ZNF469	126	Q96JG9
LRVSSDSPKDQSPPE	WDR62	976	O43379
LAPARTPPDSVKDAS	ZNHIT2	156	Q9UHR6
SPLDKSQVRTEPPKE	ZNF217	106	O75362
PFLSDSKPSDRERSP	SLC4A4	1056	Q9Y6R1
SSSPTRETDPLGKPR	ABI3BP	776	Q7Z7G0
SKRALPRDPSSEVPS	SMC5	16	Q8IY18
PRDPSSEVPSKRKNS	SMC5	21	Q8IY18
DSLSSPRKNPLERSP	UHRF1BP1	431	Q6BDS2
LDEISSRSPPEKPKQ	ZFYVE26	696	Q68DK2
KKPETEAARAQPTPS	WDR5	6	P61964
APSSETFRKEPEKPQ	ZBTB40	131	Q9NUA8
PSRQAEPPKKEAATT	ZC3H18	491	Q86VM9
SSPKEVPATPSSRRD	NACA	1511	E9PAV3
EPSKEPSSPSAQLRD	MYRIP	536	Q8NFW9